CTNM
Price
$11.70
Change
-$0.76 (-6.10%)
Updated
Oct 17 closing price
Capitalization
328.09M
18 days until earnings call
PROK
Price
$2.97
Change
-$0.07 (-2.30%)
Updated
Oct 17 closing price
Capitalization
400.93M
30 days until earnings call
Interact to see
Advertisement

CTNM vs PROK

Header iconCTNM vs PROK Comparison
Open Charts CTNM vs PROKBanner chart's image
Contineum Therapeutics
Price$11.70
Change-$0.76 (-6.10%)
Volume$102.7K
Capitalization328.09M
ProKidney
Price$2.97
Change-$0.07 (-2.30%)
Volume$790.08K
Capitalization400.93M
CTNM vs PROK Comparison Chart in %
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CTNM vs. PROK commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CTNM is a Hold and PROK is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 19, 2025
Stock price -- (CTNM: $11.70 vs. PROK: $2.97)
Brand notoriety: CTNM and PROK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CTNM: 48% vs. PROK: 36%
Market capitalization -- CTNM: $328.09M vs. PROK: $400.93M
CTNM [@Biotechnology] is valued at $328.09M. PROK’s [@Biotechnology] market capitalization is $400.93M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CTNM’s FA Score shows that 1 FA rating(s) are green whilePROK’s FA Score has 0 green FA rating(s).

  • CTNM’s FA Score: 1 green, 4 red.
  • PROK’s FA Score: 0 green, 5 red.
According to our system of comparison, CTNM is a better buy in the long-term than PROK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CTNM’s TA Score shows that 5 TA indicator(s) are bullish while PROK’s TA Score has 6 bullish TA indicator(s).

  • CTNM’s TA Score: 5 bullish, 3 bearish.
  • PROK’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, both CTNM and PROK are a good buy in the short-term.

Price Growth

CTNM (@Biotechnology) experienced а -1.52% price change this week, while PROK (@Biotechnology) price change was -1.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

CTNM is expected to report earnings on Nov 05, 2025.

PROK is expected to report earnings on Nov 18, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PROK($401M) has a higher market cap than CTNM($328M). PROK YTD gains are higher at: 75.740 vs. CTNM (-20.137). CTNM has higher annual earnings (EBITDA): -57.1M vs. PROK (-157.52M). PROK has more cash in the bank: 295M vs. CTNM (175M). PROK has less debt than CTNM: PROK (4.42M) vs CTNM (5.75M). PROK has higher revenues than CTNM: PROK (527K) vs CTNM (0).
CTNMPROKCTNM / PROK
Capitalization328M401M82%
EBITDA-57.1M-157.52M36%
Gain YTD-20.13775.740-27%
P/E Ratio26.40N/A-
Revenue0527K-
Total Cash175M295M59%
Total Debt5.75M4.42M130%
TECHNICAL ANALYSIS
Technical Analysis
CTNMPROK
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 2 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
72%
Momentum
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
66%
MACD
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 2 days ago
76%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
69%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
82%
Bullish Trend 4 days ago
74%
Declines
ODDS (%)
Bearish Trend 17 days ago
87%
Bearish Trend 2 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
85%
Bearish Trend 2 days ago
68%
Aroon
ODDS (%)
Bullish Trend 2 days ago
76%
Bullish Trend 2 days ago
73%
View a ticker or compare two or three
Interact to see
Advertisement
CTNM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
PROK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAGIY36.540.24
+0.66%
AIA Group, Ltd.
ERKH14.350.02
+0.11%
Eureka Homestead Bancorp Inc.
FOVSY10.92N/A
N/A
Ford Otomotiv Sanayi AS
RHCGF1.75N/A
N/A
Ryman Healthcare Ltd.
YIPCF0.25N/A
N/A
Yip's Chemical Holdings Ltd.

CTNM and

Correlation & Price change

A.I.dvisor tells us that CTNM and VYGR have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CTNM and VYGR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTNM
1D Price
Change %
CTNM100%
-6.10%
VYGR - CTNM
28%
Poorly correlated
-7.13%
CCCC - CTNM
27%
Poorly correlated
-4.44%
MREO - CTNM
27%
Poorly correlated
+2.50%
XNCR - CTNM
26%
Poorly correlated
-1.20%
PROK - CTNM
26%
Poorly correlated
-2.30%
More